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ABSTRACT
Genome-wide association studies have discovered a
large number of genetic variants in human patients
with the disease. Thus, predicting the impact of these
variants is important for sorting disease-associated
variants (DVs) from neutral variants. Current meth-
ods to predict the mutational impacts depend on evo-
lutionary conservation at the mutation site, which is
determined using homologous sequences and based
on the assumption that variants at well-conserved
sites have high impacts. However, many DVs at less-
conserved but functionally important sites cannot be
predicted by the current methods. Here, we present
a method to find DVs at less-conserved sites by pre-
dicting the mutational impacts using evolutionary
coupling analysis. Functionally important and evo-
lutionarily coupled sites often have compensatory
variants on cooperative sites to avoid loss of func-
tion. We found that our method identified known
intolerant variants in a diverse group of proteins.
Furthermore, at less-conserved sites, we identified
DVs that were not identified using conservation-
based methods. These newly identified DVs were
frequently found at protein interaction interfaces,
where species-specific mutations often alter interac-
tion specificity. This work presents a means to iden-
tify less-conserved DVs and provides insight into
the relationship between evolutionarily coupled sites
and human DVs.
INTRODUCTION
As sequencing technology has advanced, many non-
synonymous variants have been identified in a number of
genome-wide association studies (GWASs). Therefore, it is
important to evaluate the impacts of these variants on hu-
man health and disease, because functional consequences
may vary among variants. To this end, many computa-
tional methods have been developed to predict the impacts
of genetic variants (1–5). Most methods depend on evo-
lutionary conservation by assuming that functionally im-
portant residues in proteins are conserved and that vari-
ants in well-conserved residues have a greater impact. These
conservation-based methods are mostly used to sort be-
tween disease-associated and neutral variants in GWASs
(6,7).
However, conservation-based methods cannot predict
the impact of disease-associated variants (DVs) for less-
conserved residues, thoughDVs have been found in residues
that are less conserved (8). For instance, the K329E vari-
ant of acyl-CoA dehydrogenase (ACADM) is associated
with medium-chain acyl-CoA dehydrogenase (MCAD) de-
ficiency, which is characterized by hypoglycemia and sud-
den death (MIM: 201450) (9,10). However, this variant
could not be identified by conservation-based methods,
such as SIFT and PROVEAN (11,12), because it occurs at a
site which is less conserved in multiple sequence alignments
(MSAs). Thus, another evolutionary approach is needed to
identify variants of residues that are not well conserved but
are associated with human disease.
Coevolutionary analyses have emerged as the principle
for predicting DVs. Evolutionarily coupled residues are de-
termined on the basis of the statistical power of covariation
patterns in theMSA. Covariation often occurs when a vari-
ant at a functionally important residue results in the devel-
opment of compensatory variants at cooperative residues to
avoid a loss of function. Thus, evolutionary coupling sug-
gests that the two residues are linked to carry out impor-
tant structural or functional roles. Specifically, the quantifi-
cation of covariation strength among all possible residues
predicts variant impacts on proteins (13–17). Moreover, the
analysis of pairwise and direct covariation strength among
residues, excluding the effect from other positions (i.e. di-
rect coupling analysis), has been applied to predict three-
dimensional contacts in protein and RNA structures (18–
25).
Here, we hypothesized that our approach based on evo-
lutionary coupling ‘number’, which focuses on how many
evolutionary couplings a residue has, would optimize the
discovery of DVs at less-conserved sites. Functional prop-
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Figure 1. Outline of variant impact prediction using coevolution (CE)
scores. The CE scores for amino acid variants were calculated by multi-
plying two coevolutionary matrices: the CN and the CC. (A) Schematic di-
agram of the CN calculation. The colors of the circles indicate the types of
amino acids. Curved lines represent evolutionary couplings between sites,
and the numbers above the lines denote the order of the couplings at a
site. Circles and straight lines represent theMSAs for the homologous pro-
teins. (B) Schematic diagram of CC calculation. CC scores compared the
frequency of amino acid pairs between wild-type and variant pairs at cou-
pled sites from MSAs.
erties, especially for less-conserved residues, such as protein
conformational change (26), allosteric regulation (27), sub-
strate specificity determining (28) and protein–protein in-
teractions (PPIs) (29), were known to be associated with
evolutionary coupling number. Moreover, the residues with
a high coupling number were differentially located from the
residues with high coupling strength, although they share
the coevolution principle. Specifically, the high coupling
numbers of those residues were driven bymultiple moderate
covariation scores rather than a few strong scores (30).
In this study, we used the evolutionary coupling num-
ber to develop a computational method to predict the im-
pacts of DVs at less-conserved sites. Specifically, we pre-
dicted variant impacts by developing the coevolution (CE)
score, which is calculated by multiplying two coevolution-
arymatrices: the coupling number (CN) and the cost of cou-
pling (CC) (Figure 1). The CN indicates the evolutionary
importance of the residue where a variant occurs by mea-
suring how many residues are evolutionarily coupled with
the residue at the variant site. When a residue with a vari-
ant is highly coupled, the CN becomes high and indicates
functional importance for the residue. In contrast, the CC
measures the influence of the amino acid change of the vari-
ant on evolutionary couplings and indicates the evolution-
ary tolerance of the altered amino acid pairs in the cou-
pled residues. Specifically, when altered pairs have a low fre-
quency between homologous proteins relative to wild-type
pairs, CC becomes high and indicates that the variants are
intolerant.
We validated the ability of the CE score to accurately
predict the impact of variants by experimentally measuring
variant impacts from five saturated mutagenesis studies. We
found that theCE score identified intolerant variants at sites
that were less conserved and would not be identified by con-
ventional methods.Moreover, integrating the CE score with
conservation-based methods improved the ability to predict
mutational impacts. When we applied CE scores to iden-
tify DVs in humans, we found that our method discovered
1261 disease-associated variants at less-conserved sites that
could not be identified by current methods. Interestingly,
DVs found by our method often occurred at the interfaces
of PPIs on protein surfaces. In summary, the CE score en-
ables the identification of functionally important DVs from
GWASs. We also provide precalculated CE scores for all
possible human gene variants on a user-friendly compan-
ion site (https://sbi.postech.ac.kr/w/CE).
MATERIALS AND METHODS
Generation of multiple sequence alignments (MSAs)
An average of 182 homologous sequences per protein
were obtained from the UniRef90 database of nonredun-
dant protein sequences (released 08/2017) (31) using PSI-
BLAST (E-value < 0.001) (32). We omitted columns with
a gap of more than 20% and with completely conserved re-
gions and excluded proteins with fewer than 10 homologous
sequences from the analysis. We aligned sequences that had
<90% identity and were 0.7–1.3 × the length of the query
sequence, using MUSCLE with the default options (33).
The resulting MSAs of the human proteins are available
from our companion site (https://sbi.postech.ac.kr/w/CE).
Calculating coupling number (CN)
Evolutionary couplings of protein residues were chosen ac-
cording to a length-dependent threshold based on the co-
varying strengths of residue pairs (13,14). We calculated the
covarying strengths using the McLachlan-based substitu-
tion correlationmethod, whichmeasures the correlations of
substitution patterns between two different sites in anMSA
using similarity scores based on a position-specific matrix
(13,34–36). The length-dependent threshold was chosen by
multiplying the protein lengths (L). Specifically, we deter-
mined a threshold to be twice the protein length (2L), which
has been systematically examined to optimize the coupling
analysis (26,27). In other words, in a protein with length
L, there are 2L number of couplings. We counted and nor-
malized the number of coupled pairs for each residue and
defined that number as the CN. The normalization was as-
signed by converting CNs into the corresponding percentile
rank scores that ranged from 0 to 1 to correct for the differ-
ent score distributions among the proteins. The calculated
CNs of variants in human proteins are also available at our
companion site.
Calculating cost of coupling (CC)
To examine how evolutionarily coupled sites are influenced
by altering the amino acid type, we measured the evolu-
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tionary tolerance of altering amino acid pairs for the cou-
pled residues. We assumed that evolutionarily unfavorable
amino acid pairs, which are rarely observed in homologous
proteins, have detrimental impacts. Specifically, we use the
entropy of the amino acid pair distribution in two aligned
columns that are evolutionarily coupled. The entropy of two
evolutionarily coupled residues i and j is as follow:
Si, j = ln N!∏
α,β ni, j (α, β)!
N is the total number of amino acid pairs in the aligned
columns of the residues i and j. α and β are wild-type amino
acids on the residues i and j. ni, j (α, β) is the number of α-β
amino acid pairs in aligned columns i and j. CC was mea-
sured by averaging entropy differences caused by a variant
in residue i paired with its coupled residues. When a variant
from α to γ occurs in the residue i, the CC of the variant is
as follows:
Si, j (α → γ ) = −ln ni, j (γ, β) + 1ni, j (α, β)
CCi (α → γ ) =
∑
j∈C Si, j (α → γ )
|C|
γ is altered amino acid of residue i, and β is the wild-type
amino acid for the residue j. C is a group of evolutionarily
coupled partners of the residue i. The calculated CCs of all
possible variants in human proteins are also available at our
companion site.
Calculating coevolution (CE) scores
The CE score was calculated by multiplying the CN and the
CC. The formulation of CE scores is outlined in Figure 1 in
more detail.
Data set collection
We collected five proteins with impacts of variants, which
were measured from saturation mutagenesis experiments
(Table 1). For reliable and unbiased validation, we selected
experiments in which more than 95% of all residues were
replaced by more than five amino acids on average. We
classified the variants as intolerant or tolerant according
to changes in the protein activities of variants relative to
that of the wild-type protein. LacI and lysozyme mutage-
nesis experiments provided the impacts of variants as the
Boolean values according to the change in protein func-
tion or organism fitness: intolerant or tolerant. In contrast,
TP53, APH(3′)-II and BLAT mutagenesis studies provided
impacts as continuous values. In those experiments, we de-
fined intolerant variants as those that had <50% of wild-
type activity.
To assess the ability of the CE score to discriminate be-
tween known disease-associated variants (DVs) and com-
mon polymorphic variants (CVs), we obtained DVs and
CVs from the UniProt humsavar list (released 04/2018)
(37), ClinVar (38) and ExAC (39). We collected 29 288 DVs
annotated with ‘disease’ in the humsavar and 17 523 DVs
annotated with ‘pathogenic’ in the ClinVar. Between the
two DV sets, 10 051 DVs overlapped. We collected 39 167
CVs that are annotated with ‘polymorphism’ (variants with
no known disease association) in the humsavar list. From
the ExAC, 4244 CVs with high allele frequency (AF) were
selected as CVs (AF > 0.1). Between the two CV sets, 2671
CVs overlapped.
Conventional methods to predict mutational impacts of vari-
ants
To compare the CE score with scoring by conventional
methods, we collected SIFT (5), Polyphen2 (1), PROVEAN
(12), EVmutation (17) and CS (ConServation) scores (40).
The SIFT scores were calculated using local installation of
SIFT. The Polyphen2, PROVEAN and EVmutation scores
of DVs and CVs were obtained using precalculated scores.
The CS score is one of the conservation-based methods
for predicting variant impacts by measuring entropy differ-
ences for the amino acid distribution in a single-aligned col-
umn with a variant (40).
Prediction performance test
To evaluate prediction performances of the CE, CS, SIFT
and integrated scores without specific thresholds, we com-
puted receiver operating characteristics (ROC) curves. We
defined true positive (TP) as the number of correctly pre-
dicted intolerant variants or DVs, true negative (TN) as
the number of correctly predicted tolerant variants or CVs,
false positive (FP) as the number of erroneously predicted
tolerant variants orCVs and false negative (FN) as the num-
ber of erroneously predicted intolerant variants orDVs. The
ROC curve was created by plotting the true positive rate,
which is the fraction of the TP over TP + FP, and the false
positive rate, which is the fraction of FP over TN + FP,
at various threshold settings. To measure prediction perfor-
mance, we computed the area under the ROC curve (AUC).
To evaluate the predictive abilities of the CE, CS, SIFT
and integrated scores at specific thresholds, we determined
the best threshold for each score using training sets by
choosing a threshold that maximized accuracy. To ensure
a fair comparison, we also determined thresholds for the
SIFT score. The accuracy was calculated as follows:
Accuracy = TP + TN
TP + FN + TN + FP
Then, we employed several parameters to measure
performance, including sensitivity, precision, accuracy,
balanced accuracy, the Matthews correlation coefficient
(MCC) and the F1 score using test sets. These performance
parameters were calculated as follows:
Sensitivity = TP
TP + FN
Precision = TP
TP + FP
Balanced accuracy =
( TP
TP+FN + TNTN+FP
)
2
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Table 1. Collection of five high-throughput saturated mutagenesis studies used for analysis
Identifier Number of variants Sequence length
Number of variants
per residue
Ratio of the residues
with variants PMID
LacI 4041 329 12.28 1.00 8046748
Lysozyme 2015 164 12.29 0.99 1942069
TP53 2314 393 5.89 1.00 27328919
APH(3′)-II 4961 264 18.79 1.00 24914046
BLAT 5198 286 18.17 1.00 24567513
The number of variants per site was calculated by dividing the number of variants by sequence length.
MCC = TP × TN − FP × FN√
(TP + FP) (TP + FN) (TN + FP) (TN + FN)
F1 score = 2 × Precision × Sensitivity
Precision + Sensitivity
The prediction performances of the scores were com-
pared by random forest classifiers that construct multiple
training sets and by fitting a decision tree (41). The Python
package ‘sklearn.ensemble’ was applied and used to con-
struct 1000 trees with maximum depth three. For valid
measurements of prediction performances, we performed
Monte Carlo cross-validation (100 times), randomly split-
ting the dataset into training (90%) and testing (10%) sets.
The classifiers were constructed with a single feature (CE,
CS or SIFT score) or two features (CE and CS scores or
CE and SIFT scores) of the training set. To analyze the pre-
diction performance of each classifier, sensitivity, precision,
balanced accuracy, theMCC and the F1 score of prediction
results of the testing set were measured.
Principal component analysis (PCA)
For the Principal component analysis (PCA) of DVs and
CVs, we used the standard R function ‘prcomp.’ The PCA
was performed using eight scores (CN, CC, CE, CS, SIFT,
Polyphen2, PROVEANandEVmutation scores). To use the
same directionality of each score as ameasure of variant im-
pact (with a high score indicating a larger impact), wemulti-
plied −1 by SIFT, PROVEAN and EVmutation scores. We
scaled each score to have unit variance before the analysis,
using the scale = T option. We chose the first two principal
components that cumulatively accounted for >88% of the
total data variance.
Analysis of structural features
To classify residues with DVs or CVs as interface or non-
interface residues, we used Interactome INSIDER and In-
ferred Biomolecular Interaction Server (IBIS) databases
(42,43). To ensure the quality of the data, we only used in-
terfaces that had the highest confidences, which included
interface residues calculated from PDB structures. Addi-
tionally, we classified the remaining residues as either ‘the
rest of surface’ or the ‘protein core.’ To assign these clas-
sifications, we analyzed the PDB structures using NAC-
CESS (44). We mapped human proteins onto PDB struc-
tures using UniProt entries in PDB, which are provided by
RCSB PDB (https://www.rcsb.org/pdb/secondary.do?p=v2/
secondary/other download.jsp). We classified residues as
‘the rest of surface’ if they were in an accessible solvent area
of the protein that was at least 10% of the residue’s total sur-
face. All other residues were classified as protein core. We
only analyzed proteins with both INSIDER and PDB data,
excluding 83 variants that were annotated as interface and
protein core. Overall, we analyzed the structural features of
8191 variants for 567 proteins.
RESULTS
Prediction of mutational impacts using evolutionary coupling
analysis
We created a computational method to predict the impacts
of sequence variants at less-conserved sites based on evolu-
tionary coupling analysis. The CE score was calculated by
multiplying the CN and CC.
CN indicates the evolutionary importance of the residue
with a variant and is measured by evolutionary coupling
analysis (Figure 1A). To calculate the CN, we examined
the evolutionary couplings between residues using homol-
ogous proteins. The CN is the normalized number of cou-
pled residues that a variant has. We used evolutionary cou-
pling to predict the impacts of variants at less-conserved
residues, because it is reported that residues that are evo-
lutionarily coupled with many other sites in the protein are
important for allosteric regulation and protein conforma-
tional changes, even though they are less conserved between
homologous protein sequences (26,27). ACNof 1 for a vari-
ant indicates that the variant occurs at the most coupled
residue in the protein sequence, whereas a CN of 0 indicates
that the variant occurs at the least coupled residue.
By contrast, CC measures the influence of an amino
acid change on the evolutionarily coupled residues (Fig-
ure 1B). When a functionally important residue is replaced
by a different amino acid, the impact depends on the type
of amino acid that was replaced (45). To quantify the im-
pact of the replacement, we compared the frequencies of
the changes between the wild-type and variant amino acid
pairs in the coupled residues of homologous proteins using
MSAs. Amino acid pairs with high impact are usually less
frequent, whereas those with low impact are usually more
frequent (46). We determined the CC by estimating the en-
tropy differences of the pair distributions for the coupled
residues of wild-type and variant pairs. To examine vari-
ant impacts on evolutionarily coupled sites, we measured
the average of entropy differences of the amino acid pairs at
coupled sites.
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Validation of the CE score for predicting variant impacts
To confirm that the CN, CC and CE scores can predict the
impact of variants, we analyzed the scores of amino acid
variants with experimentallymeasured impacts. To this end,
we used five high-throughput saturated mutagenesis studies
(Table 1) (47–51). To ensure an unbiased evaluation of the
scores for possible variants on a protein, we only chose the
studies in which >95% of the amino acid residues in a pro-
tein sequence were replaced by five or more amino acids on
average. For example, the lysozyme mutagenesis study pro-
vided phenotypic outcomes for 163 of the 164 residues, with
an average of 12.28 variants per residue (coverage 99.39%).
We classified variants as intolerant or tolerant according
to experimental measurements. Intolerant variants had less
protein activity or organismal fitness than tolerant ones.
We found that CN, CC and CE scores could be used to
predict the impacts of the variants. Specifically, we calcu-
lated the CN, CC and CE scores for the variants (Supple-
mentary Data S1). The CN, CC and CE scores of intoler-
ant variants were significantly higher than those of toler-
ant variants, for all the experimental data sets (Figure 2A
and 2B; Supplementary Figure S1). The average CN, CC
and CE scores of the intolerant variants for the lysozyme
data were 0.77, 3.61 and 2.75, respectively, whereas those
of the tolerant variants were 0.71, 2.65 and 1.89, respec-
tively (Mann–Whitney U test: CN, P = 7.7 × 10−11; CC, P
= 1.0× 10−30; CE, P= 1.7× 10−40). For example, D10Y of
lysozyme had an inhibitory effect on the plaque formation
of bacteriophage and is predicted as an intolerant variant
with a high CE score of 3.21. In contrast, K13F of lysozyme
did not have the same effect on plaque sizes and is predicted
as a tolerant variant with a low CE score of 1.32.
We also observed that integrating the CN and CC scores
into theCE score improved the ability to predict the impacts
of variants. To compare the predictive abilities of the scores,
we analyzed the ROC curves. We found that the AUC for
the CE score was higher than those of the CN and CC (Fig-
ure 2C and Supplementary Figure S2). The average AUCs
for CN, CC and CE scores were 0.60, 0.72 and 0.75, respec-
tively. We note that the CC and CN correlated poorly (Sup-
plementary Figure S1, Pearson correlations ranged from
−0.16 to 0.29), suggesting the distinct explanatory power of
CN and CC for the impacts of variants. Therefore, the inte-
gration of CN and CC is necessary to accurately predict the
variant impact.
Integrating CE scores with conservation-based methods im-
proved the prediction of variant impacts
We compared the predictions made by the CE scores with
the two different conservation-based methods, the conser-
vation (CS) and SIFT scores (4,5). We confirmed that the
intolerant variants specifically identified by CE scores oc-
curred at significantly less-conserved sites than variants
identified by the CS or SIFT scores (Figure 3; Supplemen-
tary Figures S3 and 4;Mann–WhitneyU test). For example,
for lysozyme variants, the intolerant variants specific to the
CE score were found in less-conserved residues (n = 135,
average conservation = 0.67) compared to those predicted
by both CE and CS scores (n = 105, average conservation
= 0.92, P = 5.0 × 10−34) or only CS scores (n = 63, aver-
age conservation = 0.95, P = 2.0 × 10−27). In particular,
the number of newly identified intolerant variants by the
CE scores is higher than those by other conservation-based
methods. For example, the CE score identified 135 of the
458 intolerant lysozyme variants that theCS score could not
identify (Figure 3B; 29.48%); further, the SIFT score only
identified 89 variants (19.4%).
Given that the CE score and the conservation-based
scores targeted intolerant variants with different conser-
vation levels, we anticipated that integrating both scores
would improve the ability to predict variant impacts. To
prove this, we used a Monte Carlo cross-validation and ap-
plied two different standalone classifiers that relied on ei-
ther the CE or the conservation-based scores. Briefly, we
searched the optimal thresholds of CE or the conservation-
based scores of the training set to predict variant impacts.
Then, we classified a variant as intolerant if at least one
score of the variant exceeded the threshold. At last, wemea-
sured various matrices of prediction performance.
Consistent with our expectations, we found that integrat-
ing CE scores with conservation-based scores substantially
improved the predictions of variant impacts (Supplemen-
tary Figure S5). Specifically, the F1 score, MCC and bal-
anced accuracy of the integrated score were significantly
higher than for those of the conservation-based scores. For
example, the F1 score of the integrated score (CE+CS) for
lysozyme variants was 0.56 ± 0.01 (mean value ± standard
error computed over 100 cross-validations), which was sig-
nificantly higher than the F1 score for the CS score (0.40 ±
0.01; P= 9.6× 10−39, Student’s t-test). We attribute the im-
proved performance of the integrated approach to the cor-
rect identification of intolerant variants while limiting the
number of erroneously identified tolerant variants. Specif-
ically, we observed that the gain of sensitivity of the inte-
grated approaches surpassed the loss of precision in all of
the mutagenesis studies (Supplementary Figure S6). Here,
we defined sensitivity and precision by the fraction of cor-
rectly identified intolerant variants among actual intoler-
ant variants and among the variants predicted as intoler-
ant, respectively. In the case of lysozyme variants, the sensi-
tivity of the integrated score (CE+CS) improved to 0.56 ±
0.01, compared to the CS only score of 0.41 ± 0.01. When
measuring precision, we found that the integrated score was
comparable to the CS score (CE+CS, precision = 0.61 ±
0.01; CS, precision = 0.64 ± 0.01).
We considered the possibility that the intolerant variants
identified using the integrated score could also be found
by relaxing the threshold of the conservation-based scores;
however, this was not the case. We found that the integrated
score outperformed the scores obtained by adjusting the
threshold of conservation-based scores, because using the
integrated score includes more intolerant variants without
taking a significant amount of tolerant variants. To vali-
date this finding, we measured precision after changing the
threshold for the conservation-based scores and comparing
the resulting values with the integrated score.We found that
lowering the threshold for the CS scores resulted in signif-
icantly less precision relative to the precision of the inte-
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Figure 2. Systematic and unbiased performance test for variant impact predictions using five saturated mutagenesis studies. (A) CE scores of intolerant
(red) and tolerant (blue) variants. Asterisks denote significant differences for CE scores (Mann–Whitney U test, ***P < 1.0 × 10−39). (B) CN and CC
distributions of intolerant and tolerant lysozyme variants. (C) The ROC curves of the CN, CC and CE scores for predicting the impacts of variants from
the lysozyme mutagenesis study (AUCs for CE, CN and CC scores were 0.74, 0.62 and 0.71, respectively).
Figure 3. Prediction of the impacts of variants using CE and CS scores. (A) CE and CS scores of lysozyme intolerant (red) and tolerant variants (blue).
The shaded regions represent where the CE (green) or CS (yellow) scores exceed the optimal thresholds. (B) Conservation of the CE-specific, overlapping
or CS-specific intolerant variant sites.
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grated scores (CE+CS) (Supplementary Figure S7; P = 2.2
× 10−34 to 9.4 × 10−85, Mann–Whitney U test).
To prove that integration of the CE score substantially
improves the predictions of variant impacts, we also applied
amachine learningmethod, random forest classifier. Specif-
ically, we compared the prediction performances of the clas-
sifiers with a single feature (CE, CS or SIFT scores) and
those with combining features (CE and CS or SIFT scores).
The various matrices showed that the combination of the
CE score with the conservation-based scores improved the
prediction of variant impact (Supplementary Figure S8).
For example, the F1 score of the classifier combining the
CE and CS scores was an average of 0.69, which was much
higher than that using only the CS score (0.63 on average).
We also attribute the improved performance of the CE score
to an increased sensitivity while keeping the precision (Sup-
plementary Figure S9). Application of the random forest
classifiers enables a determination of the significance of the
CE scores in terms of the feature importance. The averages
of the feature importance of the CE scores ranged from 0.32
to 0.49 (Supplementary Figure S10), which suggests that the
CE score contributed to predicting the variant impacts in
the classifiers.
CE scores identify disease-associated variants at less-
conserved sites
We found that the CE score predicted human disease-
associated variants at less-conserved sites by calculating the
CE scores for 29 288 DVs and 39 167 CVs that were anno-
tated in UniProt (37) (Supplementary Data S2). We found
that the DVs had significantly higher CE scores than the
CVs (Figure 4A; P< 1.0 × 10−300, Mann–Whitney U test).
The average CE score for the DVs was 3.78, whereas that of
the CVs was 1.82. This not only demonstrates that the CE
score offers predictive power for identifying DVs but more
generally confirms the validity of using the CE score to pre-
dict the variant impacts from a more diverse protein set (n
= 12 277).
To determine the predictive ability of the CE score, we
analyzed the ROC curve (Supplementary Figure S11). The
AUC curve for the CE score was 0.82, which was compa-
rable to the conservation-based scores of the same vari-
ants (CS, AUC = 0.83; SIFT, AUC = 0.81). Moreover, the
DVs newly discovered by the CE score were found at less-
conserved residues. We observed that 1261 DVs identified
using the CE score were not identified by the CS score (Fig-
ure 4B). Indeed, CE-specific DVs were located at residues
that were significantly less-conserved than the CS-specific
DVs (Figure 4C; P= 5.5 × 10−171, Mann–Whitney U test).
We found that 2203 DVs identified using the CE score, but
not discoverable by SIFT scores, were indeed located at less-
conserved residues (Supplementary Figures S12 and 13; P
= 7.7 × 10−61, Mann–Whitney U test). Interestingly, 13
343 DVs identified from the overlapping predictions, the
sites with the DVs predicted by both CE and CS scores,
were more conserved than CE-specific DVs (Figure 4C; P
= 2.8 × 10−272, Mann–Whitney U test). We further ana-
lyzed the CC and CN components of CE predictions and
discovered that CE-specific predictions tended to have high
CNs, whereas the overlapping prediction showed high CC
contribution (Supplementary Figure S14).
Integrating the CE score with conservation-based scores to
identify more DVs
Because CE and conservation-basedmethods identified dif-
ferent DVs, we hypothesized that an integration of the CE
score with other conservation-based scores would improve
the prediction of DVs by taking more DVs (true positive)
than CVs (false positive). To test the prediction perfor-
mance, we applied Monte Carlo cross-validation and mea-
sured the various performance matrices. We found that the
increase of sensitivity was larger than the loss of preci-
sion that occurred by integration (Supplementary Figure
S15). Thus, the MCC, F1 score and balanced accuracy of
the integrated scores were significantly higher than those
of the conservation-based scores (Supplementary Figure
S16). For example, the F1 score of the integrated (CE+CS)
score was 0.78 ± 0.00, which was significantly higher than
that of the CS score (0.77 ± 0.00; P = 9.6 × 10−17, Stu-
dent’s t-test). We found consistently improved performance
when we used random forest classifiers to combine the CE
and other conservation-based scores (Supplementary Fig-
ure S17). Furthermore, we validated the improvement of
prediction using different sets of DVs and CVs from Clin-
Var and ExAC databases and found that the performance
improvements were comparable to the predictions with the
datasets taken from humsavar (Supplementary Figure S18).
We also explored the possibility that changing the thresh-
old for the CS score would achieve a similar result, though it
might also sacrifice some precision. However, we found that
changing the threshold for the CS score resulted in a signif-
icant decrease in precision compared to that when integrat-
ing the CE and the CS scores (Supplementary Figure S19;P
= 1.4 × 10−64, Mann–Whitney U test). These findings sug-
gest that the integrated score can efficiently identify more
DVs than relaxing the threshold used for conservation-
based scores.
Together with significant improvement by the integration
with CE, we hypothesized that CE is likely an orthogonal
metric of conservation-based ones. Thus, we further ana-
lyzed the difference between theCE and conventional scores
using PCA and found that the CE score has distinct ex-
planatory power comparedwith that of other scores. Briefly,
we performed PCA using eight scores (CN, CC, CE, CS,
SIFT, Polyphen2, PROVEAN and EVmutation scores) and
found that the vector of the CE score on PCA has a differ-
ent direction than those of the conventional methods (Fig-
ure 4D). This finding suggests that the integration of the CE
score with the conventional scores improves the predictive
performance for DVs. At the same time, we also found that
the vector of CN contributes less to the separation of DVs
from CVs, which suggests that the combination of CN and
CC scores into the CE score is necessary to predict variant
impacts.
Furthermore, we found that the prediction performances
of the integrated scores are better than the performances
of other methods relying on coevolutionary analysis, such
as EVmutation (17) and DeepSequence (52). Specifically,
we compared the prediction performances of these meth-
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Figure 4. Prediction of DVs and CVs using CE and conservation-based scores. (A) Distribution of CE scores for DVs (red) and CVs (blue). (B) Venn
diagram presenting the number of DVs correctly predicted by the CE (green) or CS (yellow) scores. (C) Conservation of sites with CE-specific, overlapping
and CS-specific DVs. (D) PCA plot showing the eight scores from various methods (SIFT, PROVEAN, CS, EVmutation, CC, Polyphen2 [PPH2], CE and
CN scores) projected onto the first two principal components. Dots correspond to the DVs (red) and CVs (blue) and vectors indicate the direction and
strength of variants of each score.
ods by usingMonte Carlo cross-validation based on repeats
of random subsampling (90% for the training set and 10%
for the test set). We found that the performances of our
method were greater than EVmutation for predicting vari-
ant impacts of mutagenesis and human disease-associated
residues (Supplementary Figures S20 and 21). Specifically,
the F1 score, MCC and balanced accuracy of the integrated
score (CE+CS) were significantly higher than those of EV-
mutation (P= 7.5× 10−20 to 2.2× 10−249, Student’s t-test).
In addition, we observed that our method performs compa-
rable toDeepSequence for the prediction of variant impacts
of mutagenesis (Supplementary Figure S20). Furthermore,
one might ask that different approaches used in generating
MSAs might contribute to the performance differences in
identifying DVs. We confirmed that this is not the case. We
found that CE scores calculated by differentMSA files used
in EVmutation and our method are highly correlated (Sup-
plementary Figure S22).
We found that the integrated score identified DVs at sites
that were less conserved, and these were not identified by
current conservation-based methods. The ability to predict
DVs at less-conserved sites was improved by the integrated
approach, unlike using the CS score alone (Supplemen-
tary Figure S23). As an example, K329E of ACADM is a
newly identified DV with a high CE score of 3.16. This vari-
ant is associated with MCAD deficiency (9). However, the
conservation-based scores obtained using CS and SIFT did
not identify the variant, because it is located at a site that is
less conserved among homologous protein sequences.
We then asked which diseases were associated with the
newly identified DVs by using the CE scores. We found that
the newly identified DVs were associated with various dis-
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ease classes (Table 2). To investigate these disease associa-
tions, wemapped 21 151DVs to 21 disease classes on the ba-
sis of the physiological system affected (53). When we com-
pared the use of integrated scores with the use of CS scores,
we found that the coverage of identifiedDVs increased by an
average of 4.3% for each disease class. For example, the CS
score identified 4346/5124 DVs (84.82%) associated with
metabolic diseases, whereas the integrated score (CE+CS)
identified 4516 DVs (88.13%) that were associated with the
same diseases. This result suggests that the integrated ap-
proach improved the detection of DVs that are associated
with various diseases.
DVs identified by CE scores are enriched in protein–protein
interaction interfaces
PPIs facilitate cellular functions; thus, the loss of PPIs
affects phenotypic outcomes (54). Several human disease
studies have shown that DVs tend to localize to PPI inter-
faces (55–57). However, residues at PPI interfaces are less
likely to be conserved than residues in the protein’s core;
therefore, many DVs located in PPI interfaces are not dis-
coverable with conservation-based methods. (55).
We found that using the CE score improved the iden-
tification of DVs in PPI interfaces. We analyzed the con-
servation of residues at the PPI interface and found that
the PPI interface-located residues with DVs were less con-
served than residues in the protein core (Supplementary
Figure S24;P= 3.3× 10−34,Mann–WhitneyU test). Given
that use of the CE score improved DV predictions at less-
conserved residues, we expected the integrated approach
would identify more DVs located in PPI interfaces. To ana-
lyze the structural features of the identified DVs, we investi-
gated 179 528 PPI interface residues in 4150 PPIs using In-
teractome INSIDER (42). We also analyzed protein struc-
tures from PDB to classify noninterface residues as pro-
tein core residues and the rest of the surface residues. We
found that CE-specific DVs were enriched at PPI interfaces,
whereas the CS-specific DVs were enriched in the protein
core (Figure 5A; P = 1.7 × 10−9, Fisher’s exact test). Thus,
the integrated score identified more DVs in PPI interfaces
than the CS score alone (Figure 5B). The integrated score
identified 80.3% of the DVs in the interfaces, whereas the
CS score identified only 73.8% of them. Furthermore, we
discovered that the DVs detected by CE scores tended to
have significantly higher solvent accessibility than those de-
tected by CS or SIFT scores (Supplementary Figure S25; P
= 2.0 × 10−8 to 1.2 × 10−12, Mann–Whitney U test). This
suggests that CE-specific DVs are located at the protein sur-
face.
We identified a DV found at a PPI interface, V180A of
cystathionine -synthase (CBS), which is associated with
homocystinuria (MIM: 236200). This disease causes a va-
riety of clinical phenotypes, including mental retardation,
lens dislocation and skeletal abnormalities. This variant was
not identified by a conservation-based method (SIFT score
= 0.17). However, the CE score identified this variant (CE
score= 3.28), and we also found that the V180 residue is lo-
cated at the PPI interface of a CBS homotetramer (Figure
5C). Importantly, the V180A variant is reported to reduce
homotetramer formation and decrease CBS activity (58).
When we closely examined the location of the evolution-
arily coupled residues of the variant, we found that many
evolutionarily coupled residues were located near the inter-
facial region, suggesting that correlated mutations tend to
occur within the vicinity of the variant sites (59).
As another example of a CE-specific DV identification,
we identified theM255V variant of the platelet glycoprotein
Ib alpha chain (GP1BA), which is associated with pseudo-
von Willebrand disease (VWDP). This disease is known
to cause intermittent thrombocytopenia and a prolonged
bleeding time (60). This variant was not identified by the
conservation-based method (SIFT score = 0.11) but was
identified by the CE score (CE score = 3.39). The M255
residue is located at the PPI interface of GP1BA and von
Willebrand factor (Figure 5D). When we examined the sur-
rounding residues of the DV positions, we found that many
evolutionarily coupled residues were located near the vari-
ant position proximal to the interfacial region. Notably, the
variant is reported to have an increased affinity for the in-
teracting partner protein (61).
Furthermore, we investigated the enrichment of CE-
specific DVs at various interface types, such as ligand, pep-
tide, ion, DNA, and RNA interfaces. The CE-specific DVs
tended to locate at the protein–ligand interfaces compared
to CS-specific DVs (Supplementary Table S1; P = 0.02,
Fisher’s exact test). Specifically, 25.9% of CE-specific DVs
were found at protein–ligand interface residues, whereas
21.3% of CS-specific DVs were found at protein-ligand in-
terface regions. However, we did not find significant enrich-
ment of CE-specific DVs at peptide, ion, DNA and RNA
binding regions, potentially due to the limited coverage of
the database.
DISCUSSION
DVs located at less-conserved sites are difficult to identify in
GWASs (8,62), because most GWASs rely on conservation-
based methods to differentiate between DVs and neutral
variants. However, some functional residues are not con-
served across species. Additionally, the environmental con-
ditions encountered by different species may require an al-
teration of protein function (63). Therefore, residues that
regulate protein function, such as allosteric sites or PPI in-
terfaces, may be less conserved in homologous proteins (64–
66). In this study, we developed a scoring method called the
CE score, which is based on the evolutionary coupling num-
ber of variant sites (Figure 1). We discovered that the CE
score identified DVs at less-conserved residues that could
not be identified by conservation-based methods (Figures
3B and 4C).
Initially, the CE score based on an evolutionary coupling
number appears similar to a method based on evolution-
ary coupling strength, such as EVmutation (17). However,
we found that the CE score and the EVmutation somehow
identified different DVs (Figure 4D). This result is consis-
tent with the previous report that the coupling strength and
the coupling number identified different residues in a pro-
tein (30). Specifically, DVs predicted by our method are
more likely located at less-conserved sites than those pre-
dicted by EVmutation (Supplementary Figure S26). Our
method counts how many evolutionary couplings a variant
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Figure 5. Structural characteristics of CE- and CS-specific DVs. (A) Enrichment of the CE- or CS-specific DVs at PPI interfaces, the rest of surface or
protein core. Residues were classified as ‘interface’ using the known interfacial sites annotated in the Interactome INSIDER (42). Residues were classified
as ‘the rest of surface’ or ‘protein core’ according to the relative solvent-accessible area, using a cutoff of 10%. (B) The left and the middle panels display
the proportion of the identified DVs present on interface, the rest of surface or protein core regions when using the CS or the integrated score. The panel
on the right shows the fold increase in the proportion of the identified DVs by the integrated score relative to the CS score. Examples of CE-specific DVs
located on PPI interfaces of cystathionine -synthase (PDB ID: 1JBQ) (C) and platelet glycoprotein 1b alpha chain (PDB ID: 1U0N) (D).
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Table 2. The number and the ratio of identified DVs, determined using the CS and integrated scores across disease classes
Identified DVs
Disease class whole DVs CS Integrated (CS + CE)
Metabolic 5124 4346 (84.82%) 4516 (88.13%)
Neurological 2642 1965 (74.38%) 2193 (83.01%)
Hematological 1393 1142 (81.98%) 1212 (87.01%)
Ophthalmological 1254 979 (78.07%) 1027 (81.90%)
Cancer 1121 819 (73.06%) 889 (79.30%)
Cardiovascular 1191 839 (70.45%) 871 (73.13%)
Endocrine 1011 779 (77.05%) 847 (83.78%)
Renal 970 775 (79.90%) 812 (83.71%)
Dermatological 830 667 (80.36%) 706 (85.06%)
Muscular 842 671 (79.69%) 704 (83.61%)
Connective tissue 635 564 (88.82%) 567 (89.29%)
Bone 562 503 (89.5%) 514 (91.46%)
Immunological 536 396 (73.88%) 426 (79.48%)
Skeletal 451 392 (86.92%) 411 (91.13%)
Developmental 469 374 (79.74%) 390 (83.16%)
Ear, Nose, Throat 295 245 (83.05%) 256 (86.78%)
Gastrointestinal 195 147 (75.38%) 154 (78.97%)
Respiratory 156 119 (76.28%) 131 (83.97%)
Nutritional 32 20 (62.50%) 20 (62.50%)
Psychiatric 15 8 (53.33%) 9 (60.00%)
The list of disease classes was sorted according to the number of DVs identified by the integrated (CE + CS) score.
site has. Thus, the sites with many covarying residues tend
to be less conserved, because covariation is a result of com-
pensatory amino acid changes. These two models are based
on different premises, and they may be applicable for differ-
ent purposes (67).
We found that the CE-specific DVs that were not identi-
fied by conservation-based methods were enriched at PPI
interfaces (Figure 5A). Several lines of evidence suggest
that interfacial residues are less conserved than protein core
residues, because species often rewire their interactome over
the course of evolution (66,68–69). Because of these changes
in the interactome, the conservation-based methods per-
form poorly in identifying the DVs located at PPI interfaces
(Figure 5B). However, we found that the CE score improved
DV detection at PPI interfaces.
It is possible that residue variants at PPI interfaces per-
turb PPIs and cause disease (70), highlighting the impor-
tance of detecting DVs at protein interfaces. Several meth-
ods to identify DVs at protein interfaces have been devel-
oped (71–73), but thosemethods generally rely on structural
information. Thus, the potential for DV detection has been
limited by the availability of protein structures. We expect
that use of the CE score will help facilitate the identifica-
tion of additional DVs at PPI interfaces by using protein
sequence information.
We found that the ability of CE scores to predict DVs
depends on the quality of sequence samplings. Specifically,
variant protein sequences with very narrow or very wide
ranges of relatedness among homologous proteins were not
well predicted by the CE score (Supplementary Figure S27).
The reliability of evolutionary information depends on se-
quence sampling within the MSAs (26). Highly variable
homologous sequences may provide inaccurate sequence
alignments, resulting in background noise in MSAs that
lead to misguided evolutionary analysis; by contrast, highly
conserved homologous sequences mask or minimize the
coupling signals (74,75). To address this problem, several
studies have attempted to correct and optimize biased se-
quence sampling within MSAs (75,76).
Consensus approaches to the CE score and other conven-
tional methods have considerable potential to improve the
prediction of variant impacts. Our results indicate that in-
tegrating the CE score with conservation-based scores, CS
and SIFT scores, improves the ability to detect DVs (Sup-
plementary Figures S16–S18). Other consensus tools were
also developed for predicting the impacts of variants by in-
tegrating various methods (77,78) to improve predictive ac-
curacy. In our results, we showed that the CE score covered
different DVs than other conventional conservation-based
methods (Figure 4B). Thus, we anticipate that our method
can complement conventional methods and be potentially
useful when used with consensus approaches to improve the
prediction of the impacts of DVs.
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